2020
DOI: 10.33029/2304-9529-2020-9-2-91-93
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of metabolic disorders in patients with prostate cancer receiving luteinizing hormone-releasing hormone agonists

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles